![LOGO](https://capedge.com/proxy/S-3/0001193125-21-082916/g227720logo2.jpg)
Eastman Kodak Company
March 16, 2021
Page 2
necessary or appropriate to enable us to render the opinions expressed herein. In all such examinations, we have assumed the genuineness of all signatures on all documents examined by us, the legal competence and capacity of natural persons, the authenticity of documents submitted to us as originals, and the conformity with authentic original documents of all documents submitted to us as copies or by facsimile or other means of electronic transmission, or which we obtained from the Commission’s Electronic Data Gathering, Analysis and Retrieval system or other sites maintained by a court or governmental authority or regulatory body and the authenticity of the originals of such documents that were not submitted to us as originals. We have also assumed that the books and records of the Company are maintained in accordance with proper corporate procedures.
The opinions expressed herein are limited in all respects to the New Jersey Business Corporation Act, as in effect on the date hereof, and no opinion is expressed with respect to the laws of any other jurisdiction or any effect which such laws may have on the opinions expressed herein. This opinion letter is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated herein.
Based upon the foregoing, and subject to the assumptions, qualifications and limitations stated herein, we are of the opinion that:
1. With respect to the shares of the Selling Shareholders’ Common Stock that are outstanding as of the date hereof, such shares of Selling Shareholders’ Common Stock are duly authorized, validly issued, fully paid and nonassessable.
2. With respect to the shares of the Selling Shareholders’ Common Stock that are issuable upon conversion of (a) the 4.0% Series B Convertible Preferred Stock, no par value per share, of the Company (the “Series B Preferred Stock”), (b) the 5.0% Series C Convertible Preferred Stock, no par value per share, of the Company (the “Series C Preferred Stock”), and (c) the 5.0% unsecured convertible promissory notes due May 28, 2026, issued February 26, 2021 by the Company in favor of Kennedy Lewis Capital Partners Master Fund LP and Kennedy Lewis Capital Partners Master Fund II LP (the “2026 Notes”), upon payment by the applicable Selling Shareholders of the applicable conversion price of such shares of Selling Shareholders’ Common Stock pursuant to, and in accordance with the terms and conditions of, the Certificate of Amendment to the Certificate of Incorporation setting forth the terms of the Series B Preferred Stock, the Certificate of Amendment to the Certificate of Incorporation setting forth the terms of the Series C Preferred Stock or the 2026 Notes, as applicable, assuming that a sufficient number of shares have been set aside from the Company’s authorized shares of Common Stock for the purpose of such conversion, such shares of the Selling Shareholders’ Common Stock will be duly authorized, validly issued, fully paid and nonassessable.